|
C17ORF63 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.716800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.848200E-01 |
| Normal-vs-Stage2 |
4.972400E-01 |
| Normal-vs-Stage3 |
1.101850E-01 |
| Normal-vs-Stage4 |
1.478430E-02 |
| Stage1-vs-Stage2 |
2.828600E-01 |
| Stage1-vs-Stage3 |
2.333500E-02 |
| Stage1-vs-Stage4 |
1.104770E-03 |
| Stage2-vs-Stage3 |
5.903200E-01 |
| Stage2-vs-Stage4 |
2.395000E-01 |
| Stage3-vs-Stage4 |
3.879600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.239400E-01 |
| Normal-vs-AfricanAmerican |
8.194200E-01 |
| Normal-vs-Asian |
1.165390E-01 |
| Caucasian-vs-AfricanAmerican |
6.470800E-01 |
| Caucasian-vs-Asian |
1.061240E-01 |
| AfricanAmerican-vs-Asian |
1.821610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.515600E-02 |
| Normal-vs-Female |
2.979000E-01 |
| Male-vs-Female |
2.990400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.239000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.150200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.182200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.075200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.249200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.249400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.157600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.551000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.671600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.038800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.340400E-03 |
| Normal-vs-Grade 2 |
6.433400E-01 |
| Normal-vs-Grade 3 |
7.980400E-02 |
| Normal-vs-Grade 4 |
9.427900E-02 |
| Grade 1-vs-Grade 2 |
3.157500E-02 |
| Grade 1-vs-Grade 3 |
1.684340E-03 |
| Grade 1-vs-Grade 4 |
1.744260E-03 |
| Grade 2-vs-Grade 3 |
7.138600E-03 |
| Grade 2-vs-Grade 4 |
2.263800E-02 |
| Grade 3-vs-Grade 4 |
7.271600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.836990E-01 |
| Normal-vs-ccB subtype |
5.187900E-02 |
| ccA subtype-vs-ccB subtype |
1.592540E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.964000E-01 |
| Normal-vs-N1 |
3.505600E-01 |
| N0-vs-N1 |
2.526000E-01 |
|
|
